Literature DB >> 35644946

Modulation of assembly of TDP-43 low-complexity domain by heparin: From droplets to amyloid fibrils.

Dushyant Kumar Garg1, Rajiv Bhat2.   

Abstract

TAR DNA-binding protein 43 (TDP-43) is an RNA-regulating protein that carries out many cellular functions through liquid-liquid phase separation (LLPS). The LLPS of TDP-43 is mediated by its C-terminal low-complexity domain (TDP43-LCD) corresponding to the region 267-414. In neurodegenerative disorders amyotrophic lateral sclerosis and frontotemporal dementia, pathological inclusions of the TDP-43 are found that are rich in the C-terminal fragments of ∼25 and ∼35 kDa, of which TDP43-LCD is a part. Thus, understanding the assembly process of TDP43-LCD is essential, given its involvement in the formation of both functional liquid-like assemblies and solid- or gel-like pathological aggregates. Here, we show that the solution pH and salt modulate TDP43-LCD LLPS. A gradual reduction in the pH below its isoelectric point of 9.8 results in a monotonic decrease of TDP43-LCD LLPS due to charge-charge repulsion between monomers, while at pH 6 and below no LLPS was observed. The addition of heparin to TDP43-LCD solution at pH 6, at a 1:2 heparin-to-TDP43-LCD molar ratio, promotes TDP43-LCD LLPS, while at higher concentration, it disrupts LLPS through a reentrant phase transition. Upon incubation at pH 6, TDP43-LCD undergoes gelation without phase separation. However, in the reentrant regime in the presence of a high heparin concentration, it forms thick amyloid aggregates that are significantly more SDS resistant than the gel. The results indicate that the material nature of the TDP43-LCD assembly products can be modulated by heparin which is significant in the context of liquid-to-solid phase transition observed in TDP-43 proteinopathies. Our findings are also crucial in relation to similar transitions that could occur due to alteration in the molecular level interactions among various multivalent biomolecules involving other LCDs and RNAs.
Copyright © 2022 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35644946      PMCID: PMC9300664          DOI: 10.1016/j.bpj.2022.05.042

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   3.699


  64 in total

1.  Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion.

Authors:  Steve Bourgault; James P Solomon; Natàlia Reixach; Jeffery W Kelly
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

2.  HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells.

Authors:  Shan Lu; Kelsey Gasior; Haiyang Yu; Digvijay Singh; Sonia Vazquez-Sanchez; Olga Tapia; Divek Toprani; Melinda S Beccari; John R Yates; Sandrine Da Cruz; Jay M Newby; Miguel Lafarga; Amy S Gladfelter; Elizabeth Villa; Don W Cleveland
Journal:  Science       Date:  2020-12-17       Impact factor: 47.728

3.  A Chemical Chaperone Decouples TDP-43 Disordered Domain Phase Separation from Fibrillation.

Authors:  Kyoung-Jae Choi; Phoebe S Tsoi; Mahdi Muhammad Moosa; Adriana Paulucci-Holthauzen; Shih-Chu Jeff Liao; Josephine C Ferreon; Allan Chris M Ferreon
Journal:  Biochemistry       Date:  2018-12-10       Impact factor: 3.162

4.  Liquids, Fibers, and Gels: The Many Phases of Neurodegeneration.

Authors:  Shana Elbaum-Garfinkle; Clifford P Brangwynne
Journal:  Dev Cell       Date:  2015-12-07       Impact factor: 12.270

5.  Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels.

Authors:  Masato Kato; Tina W Han; Shanhai Xie; Kevin Shi; Xinlin Du; Leeju C Wu; Hamid Mirzaei; Elizabeth J Goldsmith; Jamie Longgood; Jimin Pei; Nick V Grishin; Douglas E Frantz; Jay W Schneider; She Chen; Lin Li; Michael R Sawaya; David Eisenberg; Robert Tycko; Steven L McKnight
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

6.  Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.

Authors:  Silvia Vilasi; Rosalba Sarcina; Rosa Maritato; Antonella De Simone; Gaetano Irace; Ivana Sirangelo
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

7.  Temperature-Controlled Liquid-Liquid Phase Separation of Disordered Proteins.

Authors:  Gregory L Dignon; Wenwei Zheng; Young C Kim; Jeetain Mittal
Journal:  ACS Cent Sci       Date:  2019-05-01       Impact factor: 14.553

8.  ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.

Authors:  Liangzhong Lim; Yuanyuan Wei; Yimei Lu; Jianxing Song
Journal:  PLoS Biol       Date:  2016-01-06       Impact factor: 8.029

9.  The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity.

Authors:  Valeria Crippa; Maria Elena Cicardi; Nandini Ramesh; Samuel J Seguin; Massimo Ganassi; Ilaria Bigi; Chiara Diacci; Elena Zelotti; Madina Baratashvili; Jenna M Gregory; Christopher M Dobson; Cristina Cereda; Udai Bhan Pandey; Angelo Poletti; Serena Carra
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150

10.  Tau protein liquid-liquid phase separation can initiate tau aggregation.

Authors:  Susanne Wegmann; Bahareh Eftekharzadeh; Katharina Tepper; Katarzyna M Zoltowska; Rachel E Bennett; Simon Dujardin; Pawel R Laskowski; Danny MacKenzie; Tarun Kamath; Caitlin Commins; Charles Vanderburg; Allyson D Roe; Zhanyun Fan; Amandine M Molliex; Amayra Hernandez-Vega; Daniel Muller; Anthony A Hyman; Eckhard Mandelkow; J Paul Taylor; Bradley T Hyman
Journal:  EMBO J       Date:  2018-02-22       Impact factor: 11.598

View more
  1 in total

Review 1.  Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia.

Authors:  Mengzhu Li; Yaohua Fan; Qinglian Li; Xiaoling Wang; Lijun Zhao; Meiling Zhu
Journal:  Oxid Med Cell Longev       Date:  2022-10-06       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.